What Is Driving The China Pharma (CPHI) Stock Higher In Pre-Hour Trades?
China Pharma Holdings Inc. (NYSE: CPHI), which announced an acquisition maneuver on Tuesday, has increased 24.56% to $0.1750 in pre-market trading hours. What action has CPHI declared? The acquisition of the Dry Eye Disease (DED) Therapeutic Device Project was recently made public by China Pharma (CPHI). China Pharma’s acquired device is a patented DED device. […]
